VYNE Therapeutics Inc. - VYNE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$4.759M
QoQ value delta ($000)
+$3.44M (+260.8%)
Implied price effect (QoQ)
+74.21%
Shares
Total shares
8,231,738
QoQ shares delta
+4,257,154 (+107.11%)
Total shares held by funds (by quarter)

Market chart (VYNE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
Shay Capital LLC 942 1,624,349 0.1%
Anson Funds Management LP 739 1,274,386 0.07%
Nantahala Capital Management, LLC 580 1,000,000 0.02%
T3 Companies, LLC 548 945,000 0.68%
ACADIAN ASSET MANAGEMENT LLC 370 638,492 0.0%
KVP Capital Advisors, LP 290 500,551 0.28%
VANGUARD GROUP INC 182 314,545 0.0%
Ikarian Capital, LLC 153 264,912 0.01%
ADAR1 Capital Management, LLC 147 253,791 0.01%
GEODE CAPITAL MANAGEMENT, LLC 130 225,152 0.0%
TWO SIGMA INVESTMENTS, LP 127 220,000 0.0%
TWO SIGMA ADVISERS, LP 94 163,100 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 58 100,341 0.0%
Rangeley Capital, LLC 58 100,000 0.05%
BOOTHBAY FUND MANAGEMENT, LLC 47 81,371 0.0%
XTX Topco Ltd 45 79,040 0.0%
JANE STREET GROUP, LLC 41 72,356 0.0%
UBS Group AG 36 62,761 0.0%
GSA CAPITAL PARTNERS LLP 31 53,961 0.0%
STALEY CAPITAL ADVISERS INC 29 51,472 0.0%
BlackRock, Inc. 25 44,405 0.0%
CITADEL ADVISORS LLC 17 30,526 0.0%
Virtu Financial LLC 15 25,327 0.0%
FNY Investment Advisers, LLC 14 25,000 0.0%
NORTHERN TRUST CORP 13 23,110 0.0%